Who is sponsoring NCT03564080?

NCT03564080 is sponsored by University of Salford.

What drugs are being tested in NCT03564080?

Interventions in NCT03564080: Combined - PAD and CAD.

What condition does NCT03564080 study?

NCT03564080 studies Peripheral Arterial Disease, Cardiovascular Diseases, Intermittent Claudication, Coronary Artery Disease.

Is NCT03564080 still recruiting?

NCT03564080 is currently completed. Last updated 21 February 2023.

Last reviewed 2023-02-21 · How we verify

NCT03564080

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessing the Feasibility of Including Patients With Peripheral Artery Disease in to an Established Cardiac Rehabilitation Service.

Completed NA Last updated 21 February 2023

What this trial tests

NA trial testing Combined - PAD and CAD in Peripheral Arterial Disease in 57 participants. Completed in 11 September 2022.

Timeline

18 July 2018

Primary endpoint
28 October 2019

11 September 2022

Quick facts

Lead sponsor	University of Salford
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	57
Start date	18 July 2018
Primary completion	28 October 2019
Estimated completion	11 September 2022
Sites	1 location across United Kingdom

Drugs / interventions tested

Combined - PAD and CAD

Conditions studied

Peripheral Arterial Disease — all drugs for Peripheral Arterial Disease →
Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Intermittent Claudication — all drugs for Intermittent Claudication →
Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

University of Salford

Who can join

Eligibility, any sex, with Peripheral Arterial Disease or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will investigate if patients with peripheral artery disease (PAD) can be successfully incorporated into an already existing Cardiac Rehabilitation programme. One group of PAD patients will exercise as a group, and the other group will exercise alongside patients with coronary artery disease (CAD).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Incorporating an exercise rehabilitation programme for people with intermittent claudication into an established cardiac rehabilitation service: A protocol for a pilot study.
Caldow E, Findlow A, Granat M, Schoultz M. · · 2019 · cited 3× · PMID 31388598 · DOI 10.1016/j.conctc.2019.100389

Verify or expand the search:

Other recruiting trials for Peripheral Arterial Disease

Currently open trials in the same condition.

NCT05437562 — Randomized Clinical Trial for Ewing Amputation in the VA · NA · recruiting
NCT07427108 — Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety · NA · recruiting
NCT07336381 — Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy · NA · recruiting
NCT07076082 — Vascular Trial Associated Registry Pilot · Phase 4 · recruiting
NCT06308562 — Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease · NA · recruiting

Other University of Salford trials

Trials by the same sponsor.

NCT06503913 — Cognitive Muscular Therapy for Patients With Long-COVID and Breathing Pattern Disorder · NA · active not recruiting
NCT06103955 — OptiMuscle - Improving Respiration by Optimising Muscle Function · NA · recruiting
NCT05801510 — Cognitive Muscular Therapy for People Awaiting Knee Joint Replacement · NA · completed
NCT05611476 — Cognitive Muscular Therapy for Low Back Pain · NA · completed
NCT03132064 — The Association Between Pre-operative Pain Psychology and Hypersensitivity With Poor Functional Outcome After Knee Repla · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03564080 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Salford
Last refreshed: 21 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03564080.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing